Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients
✍ Scribed by Jean-Pierre Bronowicki; Denis Vetter; Francis Dumas; Karim Boudjema; Robert Bader; Anne-Marie Weiss; Jean-Jacques Wenger; Patrick Boissel; Marc-André Bigard; Michel Doffoel
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 828 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Systemic, high–dose interferon‐α treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of tr
## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co